Management of CLTI in an Era of BEST-CLI and BASIL-2
Dr. Alik Farber discusses his ISET 2024 presentation on the BEST-CLI and BASIL-2 trials and how to best manage patients with CLTI in the wake of these trials.
Dr. Alik Farber discusses his ISET 2024 presentation on the BEST-CLI and BASIL-2 trials and how to best manage patients with CLTI in the wake of these trials.
Visit the AHA Stroke journal booth (# 15) in the Exhibit Hall where Stroke Managing Editor, Rebecca Seastrong, can answer all your AHA/ASA and journal-related…
Department of Integrative Physiology and Anesthesiology, Baylor College of Medicine, Houston, TX (D.J.D.). Hypertension Research Laboratory, School of Biological Sciences, Monash University, Melbourne, Australia (R.R.M.,…
BackgroundRetinal ischemic perivascular lesions (RIPLs) are an indicator of ischemia in the middle retina. We aimed to determine the relationship between RIPLs and single subcortical…
“I think we really need our cardiologist community to understand the changes that are happening with value-based payment,” one expert tells Cardiovascular Business.
The 2024 ASPC Abstract Committee invites the submission of abstracts to be presented at the 2024 ASPC Annual Congress on Cardiovascular Disease Prevention August 2-4,…
Keep up-to-date with this roundup of recent studies.
More than 50% of patients with atrial fibrillation (AF) suffer from sleep disordered breathing (SDB). Obstructive respiratory events contribute to a transient, vagally mediated atrial…
In patients with obstructive hypertrophic cardiomyopathy, the cardiac myosin inhibitor aficamten improved exercise capacity and quality of life compared with placebo, according to the results…
In patients with the obesity phenotype of HF with preserved ejection, semaglutide 2.4 mg improved HF-related symptoms and physical limitations vs. placebo regardless of diuretic…
You will be using this platform to submit your abstract and contact information for the ACC Quality Summit. Please create an account by selecting “Join…